Next generation maleimides; Enabling applications from antibody-drug conjugates (ADCs) as targeted therapeutics to photochemical reactions ‘on proteins’ Seminar
- Time:
- 16:00
- Date:
- 19 October 2016
- Venue:
- Building 27, Room 2001, Chemistry, Uniersity of Southampton, SO17 1BJ
For more information regarding this seminar, please email Seung Lee at S.S.Lee@soton.ac.uk .
Event details
Dr James Baker presents a seminar as part of the Chemical Biology Diagnostics and Therapeutics reserach section's seminar series.
Next generation maleimides; Enabling applications from antibody-drug conjugates (ADCs) as targeted therapeutics to photochemical reactions ‘on proteins’
All welcome to attend.
Speaker information
Dr. James R. Baker , University College, London. Dr Jamie Baker has been a Senior Lecturer in Chemistry at UCL since 2014. He previously held posts at UCL as a Lecturer (2012-2014), and prior to that as an RCUK Research Fellow in Chemical Biology (2007-2012). His research interests are in the development and application of novel methodologies in bioconjugation, targeted therapeutics, and organic synthesis resulting in >35 peer reviewed articles, 2 granted patents and 3 further patent applications in these areas. He is also a co-founder of the spin-out company ThioLogics (www.thiologics.com), which commercialises site-specific conjugation methods for the assembly of next generation Biologics.